{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:12:30Z","timestamp":1789866750583,"version":"4.0.1"},"reference-count":97,"publisher":"Scientific Scholar","content-domain":{"domain":["cytojournal.com"],"crossmark-restriction":true},"short-container-title":["Cytojournal"],"abstract":"<jats:p>Due to the remarkably wide morphologic spectrum of reactive mesothelial cells, some of the effusion fluids may be difficult to interpret with objective certainty by cytomorphology alone. Cytomorphology of well to moderately differentiated adenocarcinomas (responsible for the bulk of malignant effusions) may overlap with floridly reactive mesothelial cells. Even mesotheliomas including diffuse malignant epithelioid mesothelioma, are usually cytomorphologically bland without unequivocal features of malignancy.<\/jats:p>\n<jats:p>The intensity of challenge depends on the interpreter\u2019s training or experience level, institutional demographics of patients (such as type of prevalent diseases, predominant sex and age group), technical support, and quality of cytopreparatory processing. In general immunocytochemistry is valuable adjunct to facilitate objective interpretation with or without other ancillary techniques as indicated. An increasing number of immunomarkers is further refining the contribution of immunohistochemistry to this field.<\/jats:p>\n<jats:p>However, application of immunohistochemistry to effusion fluids is relatively challenging because of many variables. Multiple factors such as delay after specimen collection, specimen processing related factors including fixation and storage; ambient conditions under which paraffin blocks are archived (for retrospective testing); antigen retrieval method; duration of antigen retrieval step; antibody clone and dilution; and antibody application time are identical to application of immunohistochemistry in other areas. The significant challenge related to the potential compromization of the immunoreactivity pattern due to exposure to non-formalin fixatives \/ reagents is also applicable to effusion fluid specimens.<\/jats:p>\n<jats:p>The immunoreactivity results would be compared and corelated with cumulative metadata based on the reported studies performed and validated on formalin-fixed paraffin-embedded tissue sections. Deviating from such protocols may lead to suboptimal results, which is not uncommon in clinical practice with potential compromization of patient care and related liability. Because of this, it is critical to perform immunocytochemistry on formalin-fixed cell-block sections only.<\/jats:p>\n<jats:p>In addition, unless the interpretation criteria for immunohistochemical evaluation of effusion fluids are not modified specifically, it may not be productive in resolving some challenging cases. However, this aspect is not well elaborated in the literature. A basic and critical challenge is finding and locating the cells of interest in cell-block sections of effusion fluids. A unique approach is to choose a fundamental immunopanel which highlight the mesothelial and inflammatory cells in reactive effusion fluids to create the basic map. This allows detection of a \u2018second-foreign\u2019 population which can be immunocharacterized further with the help of subtractive coordinate immunoreactivity pattern (SCIP) approach elaborated here.<\/jats:p>","DOI":"10.25259\/cmas_02_05_2021","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T12:29:16Z","timestamp":1643632156000},"page":"3","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Immunocytochemistry of effusion fluids: Introduction to SCIP approach"],"prefix":"10.25259","volume":"19","author":[{"given":"Vinod B.","family":"Shidham","sequence":"first","affiliation":[{"name":"Department of Pathology, Wayne State University School of Medicine, Karmanos Cancer Center, and Detroit Medical Center, Detroit, Michigan, USA,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lester J.","family":"Layfield","sequence":"additional","affiliation":[{"name":"Department of Pathology and Anatomical Sciences, University of Missouri, One Hospital Drive, Columbia, Missouri, USA,"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2022,1,31]]},"reference":[{"key":"10.25259\/CMAS_02_05_2021\/ref-1","first-page":"949","volume-title":"Koss' Diagnostic Cytology and Its Histopathologic Bases","author":"Koss","year":"2006","edition":"5th edn"},{"key":"10.25259\/CMAS_02_05_2021\/ref-2","first-page":"551","volume-title":"Comprehensive Cytopathology","author":"Naylor","year":"1997","edition":"2nd edn"},{"key":"10.25259\/CMAS_02_05_2021\/ref-3","author":"Tao","year":"1996"},{"key":"10.25259\/CMAS_02_05_2021\/ref-4","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/(SICI)1097-0339(199902)20:2<57::AID-DC2>3.0.CO;2-M","article-title":"Cytologic diagnosis of malignant mesothelioma, with particular emphasis on the epithelial noncohesive cell type","volume":"20","author":"Kho-Duffin","year":"1999","journal-title":"Diagn Cytopathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-5","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"key":"10.25259\/CMAS_02_05_2021\/ref-6","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1002\/cncr.9044","article-title":"Immunocytochemistry in effusion cytology: a contemporary review","volume":"93","author":"Fetsch","year":"2001","journal-title":"Cancer Cytopathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-7","doi-asserted-by":"publisher","first-page":"12","DOI":"10.4103\/cytojournal.cytojournal_20_19","article-title":"CellBlockistry: Chemistry and art of cell-block making-a detailed review of various historical options with recent advances","volume":"16","author":"Shidham","year":"2019","journal-title":"Cytojournal"},{"key":"10.25259\/CMAS_02_05_2021\/ref-8","doi-asserted-by":"publisher","first-page":"2","DOI":"10.25259\/Cytojournal_83_2020","article-title":"Cell-blocks and immunohistochemistry","volume":"18","author":"Shidham","year":"2021","journal-title":"Cytojournal"},{"key":"10.25259\/CMAS_02_05_2021\/ref-9","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1002\/dc.10039","article-title":"Comparison of three commonly used cytologic preparations in effusion immunocytochemistry","volume":"26","author":"Fetsch","year":"2002","journal-title":"Diagn Cytopathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-10","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1159\/000326434","article-title":"Thyroid transcription factor-1 immunocytochemical staining of pleural fluid cytocentrifuge preparations for detection of small cell lung carcinoma","volume":"48","author":"Liu","year":"2004","journal-title":"Acta Cytol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-11","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/S0272-2712(18)30163-X","article-title":"If cells could talk: the application of new techniques to cytopathology","volume":"18","author":"Abati","year":"1998","journal-title":"Clin Lab Med"},{"key":"10.25259\/CMAS_02_05_2021\/ref-12","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1385\/1-59259-213-9:405","volume-title":"Methods in Molecular Biology. 115: Immunocytochemical Methods and Protocols","author":"Fetsch","year":"1999"},{"key":"10.25259\/CMAS_02_05_2021\/ref-14","author":"College of American Pathologists Laboratory Accreditation Program","year":"2000"},{"key":"10.25259\/CMAS_02_05_2021\/ref-15","first-page":"99","article-title":"Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas","volume":"3","author":"Wang","year":"1995","journal-title":"Appl Immunohistochem"},{"key":"10.25259\/CMAS_02_05_2021\/ref-16","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1128\/9781555815905.ch47","volume-title":"Manual Molecular and Clinical Laboratory Immunology","author":"Shidham","year":"2006","edition":"7th edn"},{"key":"10.25259\/CMAS_02_05_2021\/ref-17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1097\/00000478-198904000-00003","article-title":"The immunohistochemical diagnosis of mesothelioma. Differentiation of mesothelioma and lung adenocarcinoma","volume":"13","author":"Ord\u00f3\u00f1ez","year":"1989","journal-title":"Am J Surg Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-18","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0344-0338(97)80054-4","article-title":"Malignant mesothelioma of the pleura: the reproducibility of the immunohistological diagnosis","volume":"193","author":"Betta","year":"1997","journal-title":"Pathol Res Pract"},{"key":"10.25259\/CMAS_02_05_2021\/ref-19","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0046-8177(99)90011-4","article-title":"The immunohistochemical diagnosis of epithelial mesothelioma","volume":"30","author":"Ord\u00f3\u00f1ez","year":"1999","journal-title":"Hum Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-20","doi-asserted-by":"publisher","first-page":"4","DOI":"10.25259\/Cytojournal_3_2021","article-title":"Cell-blocks and other ancillary studies (including molecular genetic tests and proteomics)","volume":"18","author":"Shidham","year":"2021","journal-title":"Cytojournal"},{"key":"10.25259\/CMAS_02_05_2021\/ref-21","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/dc.10364","article-title":"Immunostaining of cytology smears: a comparative study to identify the most suitable method of smear preparation and fixation with reference to commonly used immunomarkers","volume":"29","author":"Shidham","year":"2003","journal-title":"Diagn Cytopathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-22","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1742-6413-1-2","article-title":"Optimization of an immunostaining protocol for the rapid intraoperative evaluation of melanoma sentinel lymph node imprint smears with the 'MCW melanoma cocktail'","volume":"1","author":"Shidham","year":"2004","journal-title":"Cytojournal"},{"key":"10.25259\/CMAS_02_05_2021\/ref-23","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/S0046-8177(00)80255-5","article-title":"Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas","volume":"31","author":"Katoh","year":"2000","journal-title":"Hum Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-24","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1159\/000328590","article-title":"Methods of cytology smear preparation and fixation: Effect on the immunoreactivity of commonly used anti-cytokeratin antibody AE1\/AE3","volume":"44","author":"Shidham","year":"2000","journal-title":"Acta Cytol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-26","doi-asserted-by":"publisher","first-page":"2","DOI":"10.25259\/Cytojournal_83_2020","article-title":"Cell-blocks and immunohistochemistry","volume":"18","author":"Shidham","year":"2021","journal-title":"CytoJournal"},{"key":"10.25259\/CMAS_02_05_2021\/ref-27","article-title":"CellBlockistry 101","author":"Shidham","year":"2021","edition":"1st ed"},{"key":"10.25259\/CMAS_02_05_2021\/ref-28","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1097\/00000478-200308000-00001","article-title":"The immunohistochemical diagnosis of mesothelioma: a comparative study of epithelioid mesothelioma and lung adenocarcinoma","volume":"27","author":"Ord\u00f3\u00f1ez","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-29","first-page":"273","volume-title":"Atkinson Atlas of Diagnostic Cytopathology","author":"Shidham","year":"2004","edition":"2nd edn"},{"key":"10.25259\/CMAS_02_05_2021\/ref-30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1471-2407-3-15","article-title":"Improved immunohistochemical evaluation of micrometastases in sentinel lymph nodes of cutaneous melanoma with 'MCW melanoma cocktail'-a mixture of monoclonal antibodies to MART-1, Melan-A, and tyrosinase","volume":"3","author":"Shidham","year":"2003","journal-title":"BMC Cancer"},{"key":"10.25259\/CMAS_02_05_2021\/ref-31","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.5858\/2005-129-1407-IDOEMA","article-title":"Immunohistochemical diagnosis of epithelioid mesothelioma: an update","volume":"129","author":"Ord\u00f3\u00f1ez","year":"2005","journal-title":"Arch Pathol Lab Med"},{"key":"10.25259\/CMAS_02_05_2021\/ref-32","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-7020-3154-0.00003-X","volume-title":"Diagnostic Cytopathology","volume":"Ch. 3","author":"Shidham","year":"2010","edition":"3rd ed"},{"key":"10.25259\/CMAS_02_05_2021\/ref-33","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-6413-2-6","article-title":"Desmoplastic small round cell tumour: cytological and immunocytochemical features","volume":"2","author":"Granja","year":"2005","journal-title":"Cytojournal"},{"key":"10.25259\/CMAS_02_05_2021\/ref-34","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/modpathol.3800259","article-title":"Utility of D240, a novel mesothelial marker, in the diagnosis of malignant mesothelioma","volume":"18","author":"Chu","year":"2005","journal-title":"Mod Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-35","doi-asserted-by":"publisher","first-page":"64407","DOI":"10.18632\/oncotarget.19041","article-title":"Diagnostic value of D2-40 immunostaining for malignant mesothelioma: A meta-analysis","volume":"8","author":"He","year":"2017","journal-title":"Oncotarget"},{"key":"10.25259\/CMAS_02_05_2021\/ref-36","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.humpath.2005.01.019","article-title":"D2-40 and podoplanin are highly specific and sensitive immunohistochemical markers of epithelioid malignant mesothelioma","volume":"36","author":"Ord\u00f3\u00f1ez","year":"2005","journal-title":"Hum Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1440-1827.2005.01791.x","article-title":"Podoplanin as a marker for mesothelioma","volume":"55","author":"Kimura","year":"2005","journal-title":"Pathol Int"},{"key":"10.25259\/CMAS_02_05_2021\/ref-38","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s00428-006-0223-4","article-title":"Identity of M2A (D2-40) antigen and gp36 (Aggrus, T1A-2, podoplanin) in human developing testis, testicular carcinoma in situ and germ-cell tumours","volume":"449","author":"Sonne","year":"2006","journal-title":"Virchows Arch"},{"key":"10.25259\/CMAS_02_05_2021\/ref-39","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0002-9440(10)62311-5","article-title":"Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors","volume":"166","author":"Schacht","year":"2005","journal-title":"Am J Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-40","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/01.pap.0000213007.48479.94","article-title":"Podoplanin: a novel diagnostic immunohistochemical marker","volume":"13","author":"Ord\u00f3\u00f1ez","year":"2006","journal-title":"Adv Anat Pathol"},{"issue":"Suppl1","key":"10.25259\/CMAS_02_05_2021\/ref-41","first-page":"1A","article-title":"Expression of D2-40 in primary peritoneal serous carcinomas, ovarian serous carcinomas, uterine carcinomas and sex cord stromal tunors","volume":"19","author":"Chivukula","year":"2006","journal-title":"Mod Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-42","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S0002-9440(10)62311-5","article-title":"Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors","volume":"166","author":"Schacht","year":"2005","journal-title":"Am J Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-43","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0046-8177(97)90008-3","article-title":"Newly marketed tissue markers for malignant mesothelioma: immunoreactivity of rabbit AMAD-2 antiserum compared with monoclonal antibody HBME-1 and a review of the literature on so-called antimesothelioma antibodies","volume":"28","author":"Donna","year":"1997","journal-title":"Hum Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-44","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/dc.21380","article-title":"Usefulness of Claudin 4 in the cytological diagnosis of serosal effusions","volume":"39","author":"Lonardi","year":"2011","journal-title":"Diagn Cytopathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-45","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1016\/j.jasc.2020.07.012","article-title":"Efficiency and effectivity of using dual-color immunostaining with a combination of BerEp4 and vimentin as compared to BerEp4 alone on serous effusions","volume":"9","author":"Khan","year":"2020","journal-title":"J Am Soc Cytopathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-46","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1002\/cncr.20627","article-title":"Mammaglobin and CRxA-01 in pleural effusion cytology: potential utility of distinguishing metastatic breast carcinomas from other cytokeratin 7-positive\/cytokeratin 20-negative carcinomas","volume":"102","author":"Ciampa","year":"2004","journal-title":"Cancer"},{"key":"10.25259\/CMAS_02_05_2021\/ref-47","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/(SICI)1097-0142(19970225)81:1<57::AID-CNCR12>3.0.CO;2-B","article-title":"Effusion cytology of malignant melanoma. A morphologic and immunocytochemical analysis including application of the MART-1 antibody","volume":"81","author":"Beaty","year":"1997","journal-title":"Cancer"},{"key":"10.25259\/CMAS_02_05_2021\/ref-48","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/00000478-200402000-00002","article-title":"Distinction of endocervical and endometrial adenocarcinomas: immunohistochemical p16 expression correlated with human papillomavirus (HPV) DNA detection","volume":"28","author":"Ansari-Lari","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-49","article-title":"Two color immunocytochemistry for evaluation of serous cavity fluids. Poster #20 96th Annual Meeting of United States and Canadian Academy of Pathology, March 24-30, 2007 San Diego, CA","volume":"20","author":"Cihlar","year":"2007","journal-title":"Mod Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-50","doi-asserted-by":"publisher","first-page":"e305","DOI":"10.1038\/emm.2017.23","article-title":"From rabbit antibody repertoires to rabbit monoclonal antibodies","volume":"49","author":"Weber","year":"2017","journal-title":"Exp Mol Med"},{"key":"10.25259\/CMAS_02_05_2021\/ref-51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1742-6413-1-5","article-title":"Merkel cell carcinoma in a malignant pleural effusion: case report","volume":"1","author":"Payne","year":"2004","journal-title":"Cytojournal"},{"key":"10.25259\/CMAS_02_05_2021\/ref-52","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1309\/G1RA-EU9X-X6VV-3W79","article-title":"Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma","volume":"113","author":"Bassily","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-53","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1158\/1078-0432.CCR-04-2236","article-title":"Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm","volume":"11","author":"Dennis","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.25259\/CMAS_02_05_2021\/ref-54","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/cancers10040108","article-title":"Immunohistochemistry for diagnosis of metastatic carcinomas of unknown primary site","volume":"10","author":"Selves","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.25259\/CMAS_02_05_2021\/ref-55","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/(SICI)1097-0142(19990225)87:1<37::AID-CNCR7>3.0.CO;2-7","article-title":"Melanoma-associated antigen recognized by T-cells (MART-1): the advent of a preferred immunocytochemical antibody for the diagnosis of metastatic malignant melanoma in fine-needle aspirations","volume":"87","author":"Fetsch","year":"1999","journal-title":"Cancer (Cancer Cytopathol)"},{"key":"10.25259\/CMAS_02_05_2021\/ref-56","article-title":"Monoclonal Mouse Anti-human Leukocyte Common Antigen Package Insert","year":"1998"},{"key":"10.25259\/CMAS_02_05_2021\/ref-57","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1002\/dc.2840120119","article-title":"OV632 as a possible marker for malignant mesothelioma: high expectations; low specificity","volume":"12","author":"Abati","year":"1995","journal-title":"Diagn Cytopathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-58","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1002\/path.1711650209","article-title":"Immunocytochemistry of malignant mesothelioma: OV632 as a marker of malignant mesothelioma","volume":"165","author":"Delahaye","year":"1991","journal-title":"J Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-59","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1002\/dc.20208","article-title":"The value of epithelial membrane antigen expression in separating benign mesothelial proliferation from malignant mesothelioma: a comparative study","volume":"32","author":"Saad","year":"2005","journal-title":"Diagn Cytopathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-60","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1002\/cncy.20087 10.1002\/cncy.20071","article-title":"The use of immunohistochemistry to distinguish reactive mesothelial cells from malignant mesothelioma in cytologic effusions","volume":"118","author":"Hasteh","year":"2010","journal-title":"Cancer Cytopathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-61","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.5858\/arpa.2018-0273-OA","article-title":"Utility of methylthioadenosine phosphorylase compared with BAP1 immunohistochemistry, and CDKN2A and NF2 fluorescence in situ hybridization in separating reactive mesothelial proliferations from epithelioid malignant mesotheliomas","volume":"142","author":"Berg","year":"2018","journal-title":"Arch Pathol Lab Med"},{"key":"10.25259\/CMAS_02_05_2021\/ref-62","first-page":"2108","article-title":"Homozygous deletion of CDKN2A and codeletion of the methylthioadenosine phosphorylase gene in the majority of pleural mesotheliomas","volume":"9","author":"Illei","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.25259\/CMAS_02_05_2021\/ref-63","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat Genet"},{"key":"10.25259\/CMAS_02_05_2021\/ref-64","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1111\/j.1699-0463.1997.tb05099.x","article-title":"Optimization of a battery using nine immunocytochemical variables for distinguishing between epithelial mesothelioma and adenocarcinoma","volume":"105","author":"Dejmek","year":"1997","journal-title":"APMIS"},{"key":"10.25259\/CMAS_02_05_2021\/ref-65","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0003-4975(95)00045-M","article-title":"Characteristics of nine newly derived mesothelioma cell lines","volume":"59","author":"Pass","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.25259\/CMAS_02_05_2021\/ref-66","first-page":"115","article-title":"HBME-l: a monoclonal antibody useful in the differential diagnosis of mesothelioma, adenocarcinoma, and soft-tissue and bone tumors","volume":"3","author":"Miettinen","year":"1995","journal-title":"Appl Immunohistochem"},{"key":"10.25259\/CMAS_02_05_2021\/ref-67","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1046\/j.1365-2559.2003.01686.x","article-title":"The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen. p53 platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2","volume":"43","author":"Attanoos","year":"2003","journal-title":"Histopathology"},{"key":"10.25259\/CMAS_02_05_2021\/ref-68","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1002\/dc.2840090509","article-title":"Utility of BER-EP4 in the diagnosis of adenocarcinoma in effusions: an immunocytochemical study of 232 cases","volume":"9","author":"Diaz-Arias","year":"1993","journal-title":"Diagn Cytopathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-69","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/(SICI)1097-0142(19980425)84:2<101::AID-CNCR6>3.0.CO;2-S","article-title":"Utility of the antibodies CA 19-9, HBME-l, and thrombomodulin in the diagnosis of malignant mesothelioma and adenocarcinoma in cytology","volume":"84","author":"Fetsch","year":"1998","journal-title":"Cancer (Cancer Cytopathol)"},{"key":"10.25259\/CMAS_02_05_2021\/ref-70","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1046\/j.1365-2559.1998.00349.x","article-title":"E-cadherin and calretinin: a useful combination of immunochemical markers for differentiation between mesothelioma and metastatic adenocarcinoma","volume":"32","author":"Leers","year":"1998","journal-title":"Histopathology"},{"key":"10.25259\/CMAS_02_05_2021\/ref-71","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/cancers10040108","article-title":"Immunohistochemistry for diagnosis of metastatic carcinomas of unknown primary site","volume":"10","author":"Selves","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.25259\/CMAS_02_05_2021\/ref-72","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1046\/j.1365-2303.2000.00211.x","article-title":"Reactivity of six antibodies in effusions of mesothelioma, adenocarcinoma and mesotheliosis: stepwise logistic regression analysis","volume":"11","author":"Dejmek","year":"2000","journal-title":"Cytopathology"},{"issue":"Pt 2","key":"10.25259\/CMAS_02_05_2021\/ref-73","first-page":"157","article-title":"The immunohistochemistry of malignant mesothelioma","volume":"29","author":"Leong","year":"1994","journal-title":"Pathol Annu"},{"key":"10.25259\/CMAS_02_05_2021\/ref-74","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/ajcp\/112.1.75","article-title":"Role of immunohistochemistry in differentiating epithelial mesothelioma from adenocarcinoma","volume":"112","author":"Ord\u00f3\u00f1ez","year":"1999","journal-title":"Am J Clin Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-75","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/019131299281383","article-title":"Glycogen-rich mesothelioma","volume":"23","author":"Ord\u00f3\u00f1ez","year":"1999","journal-title":"Ultrastruct Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-76","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1309\/QHCA-8594-TA7P-0DVQ","article-title":"An optimized battery of eight antibodies that can distinguish most cases of epithelial mesothelioma from adenocarcinoma","volume":"114","author":"Brockstedt","year":"2000","journal-title":"Am J Clin Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-77","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s004280050393","article-title":"Detection of cancer cells in effusions from patients diagnosed with gynaecological malignancies. Evaluation of five epithelial markers","volume":"435","author":"Davidson","year":"1999","journal-title":"Virchows Arch"},{"key":"10.25259\/CMAS_02_05_2021\/ref-78","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1002\/(SICI)1097-0142(20000225)90:1<55::AID-CNCR8>3.0.CO;2-P","article-title":"Cytologic differential diagnosis among reactive mesothelial cells, malignant mesothelioma, and adenocarcinoma: utility of combined E-cadherin and calretinin immunostaining","volume":"90","author":"Kitazume","year":"2000","journal-title":"Cancer"},{"key":"10.25259\/CMAS_02_05_2021\/ref-79","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1002\/(SICI)1097-0142(19990425)87:2<83::AID-CNCR7>3.0.CO;2-S","article-title":"N-cadherin distinguishes pleural mesotheliomas from lung adenocarcinomas: a ThinPrep immunocytochemical study","volume":"87","author":"Han","year":"1999","journal-title":"Cancer"},{"key":"10.25259\/CMAS_02_05_2021\/ref-80","first-page":"929","article-title":"Value of calretinin immunostaining in differentiating epithelial mesothelioma from lung adenocarcinoma","volume":"11","author":"Ord\u00f3\u00f1ez","year":"1998","journal-title":"Mod Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-81","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1002\/(SICI)1097-0339(199903)20:3<125::AID-DC3>3.0.CO;2-V","article-title":"Ecadherin, N-cadherin, and calretinin in pleural effusions: the good, the bad, the worthless","volume":"20","author":"Simsir","year":"1999","journal-title":"Diagn Cytopathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-82","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0046-8177(97)90171-4","article-title":"Differential expression of N-cadherin in pleural mesotheliomas and E-cadherin in lung adenocarcinomas in formalin-fixed, paraffin-embedded tissues","volume":"28","author":"Han","year":"1997","journal-title":"Hum Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-83","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1002\/(SICI)1097-0142(19991225)87:6<390::AID-CNCR10>3.0.CO;2-4","article-title":"MOC-31 aids in the differentiation between adenocarcinoma and reactive mesothelial cells","volume":"87","author":"Morgan","year":"1999","journal-title":"Cancer"},{"key":"10.25259\/CMAS_02_05_2021\/ref-84","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1046\/j.1365-2559.2000.00770.x","article-title":"HBME-l, MOC-31, WT1, and calretinin: an assessment of recently described markers for mesothelioma and adenocarcinoma","volume":"36","author":"Oates","year":"2000","journal-title":"Histopathology"},{"key":"10.25259\/CMAS_02_05_2021\/ref-85","first-page":"460","article-title":"Immunohistochemistry in the differential diagnosis of mesothelioma and adenocarcinoma. Evaluation of 5 new antibodies and 6 traditional antibodies","volume":"18","author":"Chenard-Neu","year":"1998","journal-title":"Ann Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-86","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/00000478-200101000-00004","article-title":"Immunohistochemical panels for differentiating epithelial malignant mesothelioma from lung adenocarcinoma: a study with logistic regression analysis","volume":"25","author":"Carella","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-87","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1002\/(SICI)1097-0339(199806)18:6<473::AID-DC19>3.0.CO;2-E","article-title":"Hyaluronate binding probe and CD44 in the differential diagnosis of malignant effusions-disappointing results in cytology material","volume":"18","author":"Filie","year":"1998","journal-title":"Diagn Cytopathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-88","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/modpathol.3880018","article-title":"Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5\/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura","volume":"13","author":"Cury","year":"2000","journal-title":"Mod Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-89","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1097\/00000478-200008000-00031","article-title":"Value of thyroid transcription factor-1, E-cadherin, BG8, WT1, and CD44S immunostaining in distinguishing epithelial pleural mesothelioma from pulmonary and nonpulmonary adenocarcinoma","volume":"24","author":"Ord\u00f3\u00f1ez","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-90","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/dc.2840080411","article-title":"Cytologic diagnosis of malignant mesothelioma in serous effusions using an antimesothelial-cell antibody","volume":"8","author":"Donna","year":"1992","journal-title":"Diagn Cytopathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-91","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/00000478-199202000-00003","article-title":"A novel biotinylated probe specific for hyaluronate: its diagnostic value in diffuse malignant mesothelioma","volume":"16","author":"Azumi","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-92","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/00000478-199609000-00001","article-title":"Calretinin: a novel immunocytochemical marker for mesothelioma","volume":"20","author":"Doglioni","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-93","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1002\/1097-0142(20001025)90:5<312::AID-CNCR8>3.0.CO;2-M","article-title":"Diagnostic utility of calretinin immunohistochemistry in cytologic cell-block preparations","volume":"90","author":"Wieczorek","year":"2000","journal-title":"Cancer"},{"key":"10.25259\/CMAS_02_05_2021\/ref-94","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/S0344-0338(98)80065-4","article-title":"The value of anti-calretinin antibody in the differential diagnosis of normal and reactive mesothelia versus metastatic tumors in effusion cytology","volume":"194","author":"Nagel","year":"1998","journal-title":"Pathol Res Pract"},{"key":"10.25259\/CMAS_02_05_2021\/ref-95","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1002\/1097-0142(20000625)90:3<194::AID-CNCR8>3.0.CO;2-K","article-title":"Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions","volume":"90","author":"Chhieng","year":"2000","journal-title":"Cancer"},{"key":"10.25259\/CMAS_02_05_2021\/ref-96","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1002\/dc.2028","article-title":"Comparison of antibodies to HBME-l and calretinin for the detection of mesothelial cells in effusion cytology","volume":"25","author":"Fetsch","year":"2001","journal-title":"Diagn Cytopathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-97","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1097\/00000478-200311000-00003","article-title":"Application of mesothelin immunostaining in tumor diagnosis","volume":"27","author":"Ord\u00f3\u00f1ez","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-98","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/dc.10299","article-title":"Diagnostic utility and limitations of electron microscopy in effusion fluid cytology smears","volume":"29","author":"Ng","year":"2003","journal-title":"Diagn Cytopathol"},{"key":"10.25259\/CMAS_02_05_2021\/ref-99","doi-asserted-by":"publisher","DOI":"10.1097\/PAP.0b013e31817150ad","volume":"Ch. 15","author":"Shidham","year":"2007","edition":"1st ed"}],"container-title":["Cytojournal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cytojournal.com\/immunocytochemistry-of-effusion-fluids-introduction-to-scip-approach\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cytojournal.com\/immunocytochemistry-of-effusion-fluids-introduction-to-scip-approach\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T18:14:15Z","timestamp":1734545655000},"score":1,"resource":{"primary":{"URL":"https:\/\/cytojournal.com\/immunocytochemistry-of-effusion-fluids-introduction-to-scip-approach\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,31]]},"references-count":97,"alternative-id":["10.25259\/CMAS_02_05_2021"],"URL":"https:\/\/doi.org\/10.25259\/cmas_02_05_2021","relation":{},"ISSN":["1742-6413","0974-5963"],"issn-type":[{"value":"1742-6413","type":"electronic"},{"value":"0974-5963","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1,31]]},"article-number":"3"}}